Growth Metrics

Acadia Pharmaceuticals (ACAD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -14.40%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -9.89%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -0.31%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn 37.84%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.84%
Dec 31, 2025 7.65%
Sep 30, 2025 -17.11%
Jun 30, 2025 -20.34%
Mar 31, 2025 -22.56%
Dec 31, 2024 -19.39%
Sep 30, 2024 -22.54%
Jun 30, 2024 -23.34%
Mar 31, 2024 -23.49%
Dec 31, 2023 -20.45%
Sep 30, 2023 -16.63%
Jun 30, 2023 -8.08%
Mar 31, 2023 3.21%
Dec 31, 2022 23.71%
Sep 30, 2022 26.07%
Jun 30, 2022 26.98%
Mar 31, 2022 26.31%
Dec 31, 2021 34.48%
Sep 30, 2021 36.53%
Jun 30, 2021 49.36%
Mar 31, 2021 53.29%
Dec 31, 2020 50.98%
Sep 30, 2020 41.24%
Jun 30, 2020 26.59%
Mar 31, 2020 13.60%
Dec 31, 2019 1.06%
Sep 30, 2019 0.94%
Jun 30, 2019 5.76%
Mar 31, 2019 12.52%
Dec 31, 2018 14.52%
Sep 30, 2018 17.70%
Jun 30, 2018 15.04%
Mar 31, 2018 14.90%
Dec 31, 2017 68.85%
Sep 30, 2017 79.17%
Jun 30, 2017 87.50%
Mar 31, 2017 85.59%
Dec 31, 2016 74.58%
Sep 30, 2016 86.12%
Jun 30, 2016 215.78%
Mar 31, 2016 343.84%
Dec 31, 2015 274.33%
Sep 30, 2015 220.19%
Jun 30, 2015 170.11%
Mar 31, 2015 145.30%
Dec 31, 2014 54.14%
Sep 30, 2014 42.16%
Jun 30, 2014 33.96%
Dec 31, 2013 10.77%